BDNF/TRKB signaling has been shown to induce EMT-related changes in cervical cancer cells, including the downregulation of E-cadherin (a cell adhesion molecule) and the upregulation of mesenchymal markers such as N-cadherin and vimentin. The gene discussed is NTRK2; the disease is cervical cancer.